Pharmaceutical Intermediates

Manufacturers of life-saving drugs and active pharmaceutical ingredients (API) need the staunchest supply chains, quality assurance, and regulatory expertise. For this reason, many pharmaceutical companies and CMOs look to Actylis for global sourcing of API and pharmaceutical intermediates. The Global Challenges of Sourcing Pharmaceutical Intermediates: Catering to the complexity and molecular diversity of modern pharmaceuticals requires an enormous amount of global coordination. Organizations around the world need to work together to supply everything from starting materials to advanced API intermediates for the production of both branded and generic drugs. Adding to the challenge, supply chains also have to be nimble. These worldwide interactions are in constant flux, due to unpredictable disruptions, shortages of raw materials, and sudden priority changes. All of these can significantly impact success if the organization doesn't have highly resilient pharmaceutical intermediates suppliers. Most pharma companies and CMOs operate at near-full manufacturing capacity, producing a wide range of API intermediates and drugs to keep up with ever-growing demand. As a result, switching pharmaceutical intermediates sourcing once a challenge occurs is rarely a viable option without significant planning and experience with many API intermediates manufacturers across the globe.